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Introduction
The European air quality standards are under 
revision, and a new directive will be deliv­
ered by the European Union (EU) in the next 
few years. As part of this process, the EU has 
indicated several specific issues of concern. 
Among the open issues is the extent of short­
term health effects of fine and coarse particle 
concentrations and components in Europe, 
and the shape of the concentration–response 
relationships between fine particles and 
mortality and morbidity. Much of the evi­
dence about short­term associations between 
fine particles [particulate matter with aero­
dynamic diameter ≤ 2.5 µm (PM2.5)] and 
health end points comes from studies con­
ducted in the United States, where a 24­hr 
National Ambient Air Quality Standard for 
PM2.5 was first introduced in 1997 (U.S. 
Environmental Protection Agency 2012). 
From that time, data on fine particles have 
been collected in many parts of the United 
States, and evidence has accumulated sug­
gesting significant effects of fine particles on 
both mortality (Ostro et al. 2006; Zanobetti 
and Schwartz 2009) and hospital admissions 
(Bell et al. 2008; Dominici et al. 2006). In 
contrast, EU legislation currently has a single 
limit value for exposure to PM2.5 based on an 
annual averaging period, without regulatory 
standards for daily concentrations. Only a 
few studies on the short­term effects of PM2.5 
on mortality or morbidity have been con­
ducted in Europe, with most conducted in a 
single city (Anderson et al. 2001; Atkinson 
et al. 2010; Belleudi et al. 2010; Halonen 
et al. 2009; Linares and Diaz 2010), and only 
one based on multiple cities in one country 
(France) (Host et al. 2008). Therefore, it is 
unclear whether previous findings can be gen­
eralized to all of Europe.
Another topic under debate in the EU 
is the role of other PM fractions on human 
health and, more specifically, whether coarse 
particles (particles with diameter 2.5–10 µm; 
PM2.5–10) are associated with health, and 
whether they should be monitored by 
European policies. This discussion was stimu­
lated by a systematic review published by 
Brunekreef and Forsberg (2005), in which 
the authors concluded that “coarse PM has 
a stronger or as strong short­term effect” on 
respiratory health (based on emergency hos­
pitalizations for respiratory outcomes) as fine 
PM. In addition, they concluded that there 
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Background: Evidence on the short-term effects of fine and coarse particles on morbidity in 
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oBjectives: We aimed to estimate the association between daily concentrations of fine and coarse 
particles with hospitalizations for cardiovascular and respiratory conditions in eight Southern 
European cities, within the MED-PARTICLES project.
Methods: City-specific Poisson models were fitted to estimate associations of daily concentrations 
of particulate matter with aerodynamic diameter ≤ 2.5 µm (PM2.5), ≤ 10 µm (PM10), and their 
difference (PM2.5–10) with daily counts of emergency hospitalizations for cardiovascular and 
respiratory diseases. We derived pooled estimates from random-effects meta-analysis and evaluated 
the robustness of results to co-pollutant exposure adjustment and model specification. Pooled 
concentration–response curves were estimated using a meta-smoothing approach.
results: We found significant associations between all PM fractions and cardiovascular admis-
sions. Increases of 10 µg/m3 in PM2.5, 6.3 µg/m3 in PM2.5–10, and 14.4 µg/m3 in PM10 (lag 
0–1 days) were associated with increases in cardiovascular admissions of 0.51% (95% CI: 0.12, 
0.90%), 0.46% (95% CI: 0.10, 0.82%), and 0.53% (95% CI: 0.06, 1.00%), respectively. Stronger 
associations were estimated for respiratory hospitalizations, ranging from 1.15% (95% CI: 0.21, 
2.11%) for PM10 to 1.36% (95% CI: 0.23, 2.49) for PM2.5 (lag 0–5 days).
conclusions: PM2.5 and PM2.5–10 were positively associated with cardiovascular and respira-
tory admissions in eight Mediterranean cities. Information on the short-term effects of different 
PM fractions on morbidity in Southern Europe will be useful to inform European policies on air 
 quality standards.
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was some evidence supporting effects of 
PM2.5–10 on cardiovascular hospitalizations, 
whereas, for overall mortality, the evidence was 
stronger for an effect of PM2.5, and  limited for 
coarse particles.
The MED­PARTICLES (“Particles size 
and composition in Mediterranean countries: 
geographical variability and short­term health 
effects”) project was specifically designed to 
address these and other related questions. 
It is financed by the EU under the LIFE+ 
framework, and aims to describe and compare 
the composition of airborne particles across 
Mediterranean cities and to estimate health 
effects associated with exposure to PM con­
centrations, PM components and sources, 
and Saharan dust and forest fires (MED­
PARTICLES 2010).
Here we present the results of an inves­
tigation of short­term associations of daily 
concentrations of PM2.5, PM2.5–10, and PM10 
(PM with aerodynamic diameter ≤ 10 µm) 
with emergency hospitalizations for cardio­
vascular and respiratory diseases in eight 
Southern European cities.
Methods
Study population. Daily counts of emergency 
hospital admissions were collected from 
national or regional health information sys­
tems for 10 European cities, between 2001 
and 2010: Milan, Turin, Bologna, Parma, 
Reggio Emilia, Modena, and Rome, Italy; 
Marseille, France; and Madrid and Barcelona, 
Spain. Because Parma, Reggio Emilia, and 
Modena are very close and share common 
environmental and sociodemographic charac­
teristics, they have been analyzed altogether 
as a single conurbation called “Emilia 
Romagna.” Hospitalizations only of residents 
≥ 15 years of age were considered. Two study 
outcomes were defined on the basis of the 
primary discharge diagnosis: cardiovascular 
hospitalizations [International Classification 
of Diseases, 9th Revision (ICD­9) codes 
390–459; and 10th Revision (ICD­10) codes 
I00–I99] (WHO 1999), and respiratory hos­
pitalizations (ICD­9 codes 460–519; ICD­10 
codes J00–J99). All data were extracted and 
collected according to a common protocol. 
Because data were anonymous and collected 
as daily counts, no informed consent was 
needed. And because the analysis on daily 
counts was conducted by a public health 
institute, there was no need for approval by 
an institutional review board.
Environmental variables. Daily concen­
trations of PM2.5, PM10, nitrogen dioxide 
(NO2), and ozone (O3) were collected in each 
city from multiple monitors belonging to air 
quality monitoring networks. Only moni­
tors with complete data for ≥ 75% of the 
study period were accepted. When a monitor 
had a missing value for a specific day, it was 
replaced by the average of the values of the 
remaining stations for that day multiplied 
by a factor equal to the ratio of the annual 
mean for the missing station over the cor­
responding annual mean for the other stations 
(Katsouyanni et al. 2001). When data from 
all monitors were missing on a day, the daily 
value was left as missing. Daily mean concen­
trations were computed for PM and NO2, 
and daily maximum 8­hr running means 
were calculated for O3. Daily PM2.5–10 was 
calculated for each station as the difference 
between PM10 and PM2.5, provided that both 
PM fractions were measured at the same sta­
tion using the same sampling methodology. 
Nine of 10 cities sampled PM concentrations 
using the gravimetric method or an equiva­
lent one, whereas only one city, Marseille, 
provided uncorrected concentrations from 
tapered element oscillating microbalance 
(TEOM) samplers. Daily mean air tempera­
ture was collected from each center, using air­
port meteorological stations where available.
Other confounders. Time­varying con­
founders were constructed according to a 
common protocol, under the assumption 
of similar behavior of the study populations 
during holidays and vacation periods. They 
include holidays (a four­level variable assum­
ing a value of 3 on Christmas and Easter; 
2 in the periods surrounding Christmas and 
Easter; 1 on isolated holidays; 0 on other 
days); summer population decrease (a three­
level variable assuming value 2 in the 2­week 
period around 15 August; 1 from 16 July to 
31 August, except for the aforementioned 
period; 0 for all other days); and influenza 
epidemics (a two­level variable assuming 0 on 
normal days and 1 on days with particularly 
high influenza episodes). Influenza epidem­
ics were identified using national influenza 
surveillance systems, where available, or were 
identified based on daily counts of hospi­
talizations for influenza (ICD­9 code 487; 
ICD­10 codes J09–J11).
Statistical analysis. The analyses were 
carried out using a two­stage approach. In the 
first stage, city­specific overdispersed Poisson 
regression models were fitted, in which the 
dependent variable was the daily count of 
hospitalizations, the exposure was the (lagged) 
daily concentration of PMx, and variables 
added for confounding adjustment. The 
adjustment model was defined a priori and, 
to reduce the potential for heterogeneity in 
the city­specific results, was the same for all 
cities. The confounders were long­term and 
seasonal time trends, air temperature, holidays, 
summer population decrease, and influenza 
epidemics. A directed acyclic graph (DAG) of 
the causal relationships under study is depicted 
in Supplemental Material, Figure S1.
Holidays, summer population decreases, 
and influenza epidemics were modeled using 
indicator variables. Time trend was adjusted 
for by introducing a three­way interaction 
term among year, month, and day of the 
week. This method has been demonstrated to 
be equivalent to a case­crossover design using 
a time­stratified approach to select control 
days (Levy et al. 2001; Lu and Zeger 2007; 
Maclure 1991). Two sensitivity analyses were 
designed to check the robustness of the results 
to time trend specification: a) a penalized 
spline of time trend with 50 knots per year 
and a smoothing parameter tuned to approxi­
mate 8 effective degrees of freedom (df) per 
year (Samoli et al. 2003); b) a penalized spline 
for time trend with the smoothing param­
eter set to minimize the absolute value of 
the sum of the partial autocorrelation func­
tions (PACF) of residuals from lag 0 to 30, 
but requiring a minimum of 3 df per year 
(Katsouyanni et al. 2009). In both cases, 
indicator variables for days of the week were 
included in the models. We performed sen­
sitivity analyses of seasonality control because 
a consensus on the method best suited for 
time trend adjustment has not been reached 
in the literature (Janes et al. 2005; Whitaker 
et al. 2007).
We controlled for the effect of tempera­
ture by modeling high and low temperatures 
separately. For high temperatures we calcu­
lated the average temperature on the current 
and previous day (lag 0–1) and fit a natural 
spline with 3 df on the lagged variable only 
for days on which the lag 0–1 temperature was 
higher than the median annual temperature 
for the city as a whole. Similarly, we adjusted 
for low temperatures by fitting a natural spline 
with 2 df for the average temperature on pre­
vious 6 days (lag 1–6) only for days on which 
the lag 1–6 temperature was below the median 
annual value for the city (Chiusolo et al. 
2011). This method accounts for differences 
in the lag structures and effects of cold and 
warm temperatures on hospitalizations while 
reducing the correlation between the two 
spline terms. We also performed an analysis 
that adjusted for potentially prolonged effects 
of warm temperatures on hospitalizations by 
replacing the lag 0–1 temperature term from 
the base model with the lag 0–6 average.
Individual pollutants were added to 
city­specific regression models adjusted for 
the a priori covariates described above. We 
evaluated the lag structure of the association 
between PMx concentrations and daily counts 
of cause­specific hospitalizations by applying 
cubic polynomial distributed lag models, with 
individual daily lags from lag 0 to 5 entered 
simultaneously in the model and constrained 
to follow a polynomial shape. In addition, 
we defined three cumulative lag structures 
a priori to represent immediate (lag 0–1), 
delayed (lag 2–5), and prolonged (lag 0–5) 
effects, and chose one of these structures as 
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the default lag for each PM–outcome com­
bination based on the meta­analytical results 
of the distributed and cumulative lag mod­
els. This choice has been applied previously 
(Stafoggia et al. 2010) as a compromise 
between a priori and data­driven approaches 
for selecting the lag structure for different 
exposure/outcome combinations.
The robustness of associations to adjust­
ment for co­exposure to other pollutants was 
evaluated by fitting two­pollutant models 
with the co­pollutant modeled using the 
cumulative lag selected as the default for the 
primary exposure–outcome combination. 
In addition, models that included O3 as the 
co­pollutant were fit using data restricted to 
the warm season only (April–September), 
in addition to year­round data. Finally, we 
investigated concentration–response functions 
between PMx and hospitalizations by fitting, 
for each city, a natural spline model for the 
exposure with two equally spaced inner knots, 
and pooling the city­specific estimates using 
a meta­smoothing approach (Schwartz and 
Zanobetti 2000).
In the second stage of the analysis, we 
pooled the city­specific results using random­
effects meta­analytical procedures according 
to the method proposed by Jackson et al. 
(2010). We tested heterogeneity among the 
city­specific results by applying the chi­square 
test from Cochran’s Q statistic, and estimated 
the amount of heterogeneity by comput­
ing the I2 statistic (Higgins and Thompson 
2002), which represents the proportion 
of total variation in effect estimates due to 
between­cities heterogeneity. We considered 
city­specific effect estimates to be significantly 
hetero geneous when I2 was > 50% and the χ2 
p­value was < 0.10.
All results are expressed as percent increases 
in hospitalizations, with 95% CI, relative 
to fixed increments in each PM fraction: 
10 µg/m3 for PM2.5, 6.3 µg/m3 for PM2.5–10, 
and 14.4 µg/m3 for PM10. These increments 
were chosen to represent a comparable amount 
of daily variability across pollutants and facili­
tate comparisons of effect estimates among the 
pollutants. More specifically, we computed 
the interquartile range (IQR) of each PM frac­
tion from the joint distribution for the eight 
cities (six cities for PM2.5–10), and scaled the 
three resulting IQRs to express PM2.5 effects 
per 10­µg/m3 increase. In addition, we report 
selected associations in the text using a com­
mon increment of 10 µg/m3 for all three 
PM fractions.
All first­stage analyses were fit using R, 
version 2.15.0 (R Development Core Team; 
http://R­project.org). Meta­analyses were 
conducted using Stata, version 11 (StataCorp, 
College Station, TX, USA).
Results
The population base comprised residents 
≥ 15 years of age in eight Southern European 
cities, totaling > 11 million inhabitants 
(Table 1). The mean daily counts of hos­
pitalizations ranged from 18 in the Emilia 
Romagna conurbation to 116 in Madrid 
for cardiovascular diseases, and from 8 in 
Bologna to 97 in Madrid for respiratory con­
ditions. The study periods were recent and 
comparable across cities, except for Marseille 
with 2001–2003 data.
Pollutant concentrations and air tem­
perature data for each city are summarized 
in Supplemental Material, Tables S1 (year­
round) and S2 (separate PM concentration 
distributions for the cold and warm seasons). 
Daily concentrations of PM10 and PM2.5 
were highest in Milan and Turin. Madrid had 
the smallest daily PM2.5 concentrations and 
the largest PM2.5–10 concentrations, result­
ing in a fine:coarse particles ratio that was 
much smaller for this city (< 1) than the oth­
ers (ranging from 1.5 to 2.2). NO2 and O3 
concentrations were similar among the cities, 
whereas temperature displayed a mild increas­
ing north–south gradient. Pearson correla­
tion coefficients between PM2.5 and PM2.5–10 
were close to 0 in Barcelona, Marseille, and 
Rome (the cities closest to the sea and there­
fore likely to be more affected by sea winds), 
but were ≥ 0.5 in the other cities (data not 
shown). NO2 concentrations were highly 
correlated with both PM2.5 and PM10 (> 0.6 
for all cities except Barcelona), whereas cor­
relations between NO2 and PM2.5–10 ranged 
from 0.17 in Marseille to 0.57 in Madrid.
Pooled estimates from polynomial dis­
tributed lag models (Supplemental Material, 
Figure S2) clearly show evidence of an imme­
diate effect of the three PM fractions on 
cardiovascular hospitalizations, up to lag 1, 
whereas associations with respiratory admis­
sions were evident until day 5.
Table 2 reports associations between PM 
and hospitalizations for the three cumulative 
lags (0–1, 2–5, and 0–5 days). Significant 
positive associations of a comparable mag­
nitude were estimated for all PM fractions 
with cardiovascular hospitalizations: incre­
ments of 10 µg/m3 in PM2.5, 6.3 µg/m3 in 
PM2.5–10, and 14.4 µg/m3 in PM10 (lag 0–1) 
were associated with 0.51% (95% CI: 0.12, 
0.90%), 0.46% (95% CI: 0.10, 0.82%), and 
0.53% (95% CI: 0.06, 1.00%) increases in 
cardiovascular admissions, respectively. When 
expressed per 10 µg/m3, corresponding esti­
mates for PM2.5–10 and PM10 were 0.73% 
(95% CI: 0.16, 1.30%) and 0.36% (95% CI: 
0.04, 0.69%), suggesting an effect of coarse 
particles around 40% higher than that of 
PM2.5 for the same increment. Associations 
between cardiovascular hospitalizations and 
PM were null for lag 2–5, and smaller or null 
for lag 0–5 (Table 2). Given these results 
and the results of the distributed lag models, 
we used lag 0–1 for subsequent analyses of 
 cardiovascular hospitalizations.
Associations with respiratory hospitaliza­
tions were strongest for all three PM frac­
tions at the cumulative lag 0–5, though the 
association was not statistically significant for 
PM2.5–10, and effect estimates were highly 
heterogeneous across cities. Specifically, 
lag 0–5 effect estimates were 1.36% (95% 
CI: 0.23, 2.49%) for a 10­µg/m3 increase 
in PM2.5, 1.24% (95% CI: –0.32, 2.82%) 
for a 6.3­µg/m3 increase in PM2.5–10, 
and 1.15% (95% CI: 0.21, 2.11%) for a 
14.4­µg/m3 increase in PM10. Associations 
were more homogeneous among cities for 
Table 1. Study populations and emergency hospital admissions for cardiovascular and respiratory causes among residents ≥ 15 years of age in the eight cities of 
the MED-PARTICLES project.
Citya Study period
Population Cardiovascular admissions Respiratory admissions
Date n n
n per 1,000 
person-years Daily mean n
n per 1,000 
person-years Daily mean
Milan 2006–2010 1 January 2008 1,299,633 71,779 11.0 39.3 34,427 5.3 18.9
Turin 2006–2010 1 January 2008 908,263 48,967 10.8 26.8 21,761 4.8 11.9
Emilia Romagnab 2008–2010 1 January 2009 529,699 19,717 12.4 18.0 10,164 6.4 9.3
Bologna 2006–2010 1 January 2008 372,256 34,568 18.6 18.9 14,103 7.6 7.7
Marseille 2001–2003 Census 1999 796,525 46,905 19.6 42.8 18,069 7.6 16.5
Rome 2006–2010 1 January 2008 2,718,768 153,176 11.3 83.9 53,825 4.0 29.5
Barcelona 2003–2010 1 January 2007 1,595,110 151,426 11.9 51.8 139,062 10.9 47.6
Madrid 2004–2009 1 January 2007 3,132,503 201,041 13.5 115.9 167,850 11.3 96.7
Total — — 11,352,757 727,579 12.6 51.4 459,261 7.9 32.5
aCities are ordered by latitude, north to south. bEmilia Romagna includes Parma, Reggio Emilia, and Modena. 
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lag 0–1, and statistically significant for the 
coarse fraction (0.60%; 95% CI: 0.08, 
1.13%) and PM10 (0.65%; 95% CI: 0.20, 
1.10%). When expressed for increments of 
10 µg/m3, the association with respiratory 
admissions was strongest for coarse particles 
(1.95%; 95% CI: –0.51, 4.48% for lag 0–5). 
We used lag 0–5 for subsequent analyses of 
association between the PM fractions and 
respiratory hospitalizations.
Pooled estimates from one­ and two­
pollutant models are reported in Table 3. 
When evaluated simultaneously, the associa­
tion between fine particles and cardio vascular 
hospitalizations (lag 0–1) was unaffected by 
adjustment for PM2.5–10 (0.49% increase 
per 10 µg/m3 PM2.5; 95% CI: 0.06, 0.91%) 
but adjusting for PM2.5 decreased the asso­
ciation between cardiovascular hospitaliza­
tions and coarse PM (0.28% increase per 
6.3 µg/m3 PM2.5–10; 95% CI: –0.09, 0.66%). 
Associations of fine and coarse particles 
with respiratory admissions (lag 0–5) both 
decreased considerably with mutual adjust­
ment (to 0.55%; 95% CI: –0.29, 1.40 for 
PM2.5, and 0.66%; 95% CI: –0.78, 2.13 for 
PM2.5–10). Adjustment for NO2 decreased 
association between PM2.5–10 and both out­
comes, whereas it decreased the association 
between PM2.5 and cardiovascular hospitali­
za tions, but strengthened the association with 
respiratory admissions. However, given the 
high correlation between PM2.5 and NO2 in 
all cities, results from two­pollutant models 
must be interpreted with caution. No con­
founding from O3 was apparent in the all­
year analysis, nor in the analysis restricted 
to the warm period. However, associations 
of PM2.5 and PM2.5–10 with both outcomes 
were much stronger and always statistically 
significant when the analyses were restricted 
to the warm period (April–September) both 
with and without adjustment for O3.
The robustness of the main findings was 
checked against model specification in three 
sensitivity analyses, whose results are summa­
rized in Table 4. In general, the case­crossover 
method adopted in the base model for the 
adjustment of time trend provided effect esti­
mates quite consistent with the spline method 
with minimization of the PACF of residuals, 
whereas associations based on models that 
used the spline method with 8 df per year were 
weaker for all particle metrics and both study 
outcomes. In addition, associations between all 
three PM fractions and respiratory admissions 
were strongest when estimated using the spline 
method with the PACF criterion. Effect esti­
mates from the sensitivity model adjusted for 
prolonged effects of warm temperatures were 
consistent with base model estimates.
Finally, Figure 1 reports the concentra­
tion–response relationships between PM2.5, 
PM2.5–10, and PM10 with cardiovascular 
Table 3. Associations between PM and hospitalizations from one- and two-pollutant models, per 
increases of 10, 6.3, and 14.4 μg/m3 for PM2.5, PM2.5–10, and PM10, respectively.
Pollutant Period
Cardiovascular admissions (lag 0–1) Respiratory admissions (lag 0–5)
Percent increase 
(95% CI) χ2 p-value I 2
Percent increase 
(95% CI) χ2 p-value I 2
PM2.5 All year 0.51 (0.12, 0.90) 0.20 29 1.36 (0.23, 2.49) 0.01 65
+ PM2.5–10 All year 0.49 (0.06, 0.91) 0.48 0 0.55 (–0.29, 1.40) 0.47 0
+ NO2 All year 0.21 (–0.28, 0.69) 0.21 28 1.63 (0.30, 2.97) 0.05 51
+ O3 All year 0.49 (0.06, 0.91) 0.18 31 1.13 (0.05, 2.23) 0.04 53
PM2.5 April–September 1.76 (0.68, 2.84) 0.18 32 4.49 (1.72, 7.35) 0.04 51
+ O3 April–September 2.11 (1.13, 3.10) 0.34 11 4.51 (1.35, 7.77) 0.03 56
PM2.5–10 All year 0.46 (0.10, 0.82) 0.33 13 1.24 (–0.32, 2.82) 0.00 74
+ PM2.5 All year 0.28 (–0.09, 0.66) 0.85 0 0.66 (–0.78, 2.13) 0.07 51
+ NO2 All-year 0.25 (–0.13, 0.62) 0.42 0 0.99 (–0.71, 2.73) 0.02 61
+ O3 All year 0.48 (0.14, 0.83) 0.41 2 1.17 (–0.45, 2.81) 0.01 70
PM2.5–10 April–September 0.90 (0.28, 1.52) 0.33 13 3.01 (0.68, 5.39) 0.07 51
+ O3 April–September 0.93 (0.37, 1.49) 0.50 0 3.03 (0.44, 5.68) 0.05 54
PM10 All year 0.53 (0.06, 1.00) 0.06 48 1.15 (0.21, 2.11) 0.04 52
+ NO2 All year 0.19 (–0.42, 0.79) 0.05 50 1.33 (–0.02, 2.69) 0.07 47
+ O3 All year 0.50 (–0.03, 1.03) 0.04 52 0.99 (0.13, 1.86) 0.17 32
PM10 April–September 2.07 (1.30, 2.85) 0.61 0 4.33 (2.59, 6.11) 0.32 14
+ O3 April–September 2.25 (1.45, 3.06) 0.83 0 4.98 (1.98, 8.06) 0.07 47
Table 4. Association between PM and hospitalizations for different model specifications, per increases 
of 10, 6.3, and 14.4 μg/m3 for PM2.5, PM2.5–10, and PM10, respectively.
Pollutant/model
Cardiovascular admissions (lag 0–1) Respiratory admissions (lag 0–5)
Percent increase 
(95% CI) χ2 p-value I 2
Percent increase 
(95% CI) χ2 p-value I 2
PM2.5
Base model 0.51 (0.12, 0.90) 0.20 29 1.36 (0.23, 2.49) 0.01 65
Trend, 8 df/year 0.28 (–0.12, 0.68) 0.11 41 0.87 (0.03, 1.72) 0.08 46
Trend, minimum PACFa 0.47 (0.14, 0.80) 0.23 25 1.64 (0.63, 2.65) 0.00 66
Temperature, lag 0–6 for warm period 0.52 (0.13, 0.91) 0.17 32 1.48 (0.29, 2.69) 0.00 69
PM2.5–10
Base model 0.46 (0.10, 0.82) 0.33 13 1.24 (–0.32, 2.82) 0.00 74
Trend, 8 df/year 0.34 (0.05, 0.63) 0.91 0 1.10 (0.01, 2.20) 0.05 55
Trend, minimum PACFa 0.53 (0.25, 0.81) 1.00 0 1.69 (0.26, 3.13) 0.00 72
Temperature, lag 0–6 for warm period 0.57 (0.26, 0.89) 0.50 0 1.40 (–0.27, 3.10) 0.00 76
PM10
Base model 0.53 (0.06, 1.00) 0.06 48 1.15 (0.21, 2.11) 0.04 52
Trend, 8 df/year 0.31 (–0.05, 0.67) 0.18 31 0.96 (0.31, 1.61) 0.26 22
Trend, minimum PACFa 0.56 (0.28, 0.84) 0.40 4 1.72 (0.85, 2.59) 0.03 55
Temperature, lag 0–6 for warm period 0.57 (0.12, 1.02) 0.07 47 1.29 (0.28, 2.32) 0.02 58
aEstimated degrees of freedom per year were 3 (Milan, Turin, Emilia-Romagna, Bologna, Barcelona), 4 (Rome), and 
5 (Marseille, Madrid) for cardiovascular hospitalization; and 3 (Turin, Bologna), 4 (Marseille, Madrid), 5 (Rome), 6 (Milan, 
Emilia-Romagna), and 9 (Barcelona) for respiratory hospitalizations.
Table 2. Associations between PM and hospitalizations per IQR increases of 10, 6.3, and 14.4 μg/m3 for 
PM2.5, PM2.5–10 and PM10, respectively.
Pollutant Lag
Cardiovascular admissions Respiratory admissions
Percent increase 
(95% CI) χ2 p-value I 2
Percent increase 
(95% CI) χ2 p-value I 2
PM2.5
0–1 0.51 (0.12, 0.90) 0.20 29 0.49 (–0.12, 1.09) 0.16 34
2–5 0.15 (–0.22, 0.53) 0.82 0 1.07 (0.04, 2.11) 0.00 71
0–5 0.49 (0.03, 0.95) 0.70 0 1.36 (0.23, 2.49) 0.01 65
PM2.5–10
0–1 0.46 (0.10, 0.82) 0.33 13 0.60 (0.08, 1.13) 0.26 23
2–5 –0.38 (–0.89, 0.12) 0.23 28 0.75 (–0.71, 2.23) 0.00 77
0–5 0.05 (–0.68, 0.78) 0.09 47 1.24 (–0.32, 2.82) 0.00 74
PM10
0–1 0.53 (0.06, 1.00) 0.06 48 0.65 (0.20, 1.10) 0.38 6
2–5 –0.06 (–0.43, 0.31) 0.47 0 0.95 (–0.03, 1.94) 0.00 68
 0–5 0.30 (–0.14, 0.74) 0.49 0 1.15 (0.21, 2.11) 0.04 52
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hospitalizations (lag 0–1) and respiratory 
hospitalizations (lag 0–5). All estimates are 
reported as percentage increases in hospital 
admissions (95% CI) associated with increas­
ing concentrations of PM2.5 and PM2.5–10 
relative to 5 µg/m3, and of PM10 relative to 
10 µg/m3. Associations of PM2.5 and PM10 
with cardiovascular hospitalizations seemed 
to be consistent with two linear functions, 
with a steeper slope for lower concentrations. 
There was no visual evidence of a departure 
from linearity for PM2.5–10 and cardiovascular 
hospitalizations, or for any of the PM metrics 
and respiratory admissions.
Discussion
We investigated the association between daily 
concentrations of fine and coarse particles and 
hospitalizations for cardiorespiratory condi­
tions in eight Mediterranean cities, finding 
evidence of harmful effects of the PM metrics 
on both study outcomes.
Evidence of short­term effects of par­
ticulate matter on mortality and morbidity 
has been described widely in the literature. 
Although the first multicenter studies focused 
on PM10 as the main exposure (Katsouyanni 
et al. 2001; Samet et al. 2000), more recently 
interest has shifted to specific PM fractions, 
constituents, and sources, with the aim of 
better elucidating the underlying biological 
mechanisms. It has been argued that the fine 
fraction of PM is the one more responsible 
for the health effects, because it includes toxic 
components such as nitrates, sulfates, acids, 
and metals originating from combustion 
Figure 1. Concentration–response relationship between PM2.5 (A), PM2.5–10 (B), and PM10 (C) with cardiovascular hospitalizations, lag 0–1 (left), and respiratory 
hospitalizations, lag 0–5 (right). Values are percent increase (95% CI) of hospital admissions associated with increases of PM2.5 and PM2.5–10 levels relative to 
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processes, and it can deposit more deeply into 
the lungs (Pope and Dockery 2006). In con­
trast, coarse particles are dominated by crustal 
materials, resuspended dust, sea salts, desert 
dust, and biogenic components including 
pollen, spores, and other plant parts (Pope 
and Dockery 2006). A systematic review con­
ducted by Brunekreef and Forsberg (2005) 
pointed toward a need to further investigate 
the health effects of PM2.5–10 based on evi­
dence that coarse and fine PM exert simi­
lar effects on respiratory outcomes, and on 
evidence supporting an association between 
PM2.5–10 and cardiovascular outcomes.
Recent multicenter studies focusing on the 
association between PM2.5 and hospitaliza­
tions in adult populations have been mainly 
conducted in North America (Bell et al. 
2008; Dominici et al. 2006; Stieb et al. 2009; 
Zanobetti et al. 2009). Dominici et al. (2006) 
investigated the effects of PM2.5 on cardiovas­
cular and respiratory hospital admissions in 
204 U.S. urban counties within the National 
Morbidity, Mortality, and Air Pollution Study 
(NMMAPS). They estimated statistically sig­
nificant increases in hospitalizations associ­
ated with a 10­µg/m3 increase in PM2.5 for a 
number of specific cardiovascular conditions, 
ranging from 0.44% (95% CI: 0.02, 0.86%) 
for ischemic heart disease hospitalizations to 
1.28% (95% CI: 0.78, 1.78%) for heart fail­
ure admissions. Positive associations were also 
reported for hospital admissions for specific 
respiratory outcomes (0.91%; 95% CI: 0.18, 
1.64% for PM2.5 on the same day and chronic 
obstructive pulmonary disease, and 0.92%; 
95% CI: 0.41, 1.43% for respiratory tract 
infection, with a 2­day lag). Similar results for 
cardiovascular hospitalizations were reported 
for another NMMAPS study (Bell et al. 
2008) of 202 U.S. counties, which estimated 
a 0.8% increase in cardiovascular admis­
sions (95% posterior interval: 0.59, 1.01) per 
10­µg/m3 increase in lag 0 PM2.5. The same 
study reported a 0.41% increase (95% pos­
terior interval: 0.09, 0.74) in all respiratory 
admissions associated with 10­µg/m3 increase 
in lag 2 PM2.5, a weaker association than 
reported by Dominici et al. (2006) for specific 
respiratory conditions. Zanobetti et al. (2009) 
investigated associations of PM2.5 concentra­
tions and components with cause­ specific 
admissions in 26 U.S. communities, and 
estimated stronger associations with cardiac 
and respiratory diseases than previous stud­
ies: specifically, a 1.89% increase (95% CI: 
1.34, 2.45) in cardiac admissions and a 2.07% 
increase (95% CI: 1.20, 2.95) in respiratory 
admissions in association with 10­µg/m3 
increase in lag 0–1 PM2.5. The authors con­
cluded that “particles originating from indus­
trial combustion processes or traffic may, on 
average, have greater toxicity.” However, evi­
dence from European studies has been weaker. 
One six­city study conducted in France (Host 
et al. 2008) reported large and statistically 
significant associations between PM2.5 and 
cardiovascular admissions (0.9% increase; 
95% CI: 0.1, 1.8 with a 10­µg/m3 increase in 
lag 0–1 PM2.5), but no associations between 
PM2.5 and respiratory diseases. Results from 
single­city European investigations (Anderson 
et al. 2001; Atkinson et al. 2010; Belleudi 
et al. 2010; Halonen et al. 2009; Linares and 
Diaz 2010) have been inconsistent.
Epidemiological studies on the short­
term effects of PM2.5–10 on hospitalizations 
are few and inconsistent. In a large U.S. 
study of 108 counties (Peng et al. 2008), a 
10­µg/m3 increase in PM2.5–10 was associated 
with a 0.36% (95% posterior interval: 0.05, 
0.68) increase in cardiovascular disease 
admissions on the same day. However, 
when adjusted for PM2.5, the association 
was still positive but no longer statistically 
significant. Two studies conducted in the 
United Kingdom (Anderson et al. 2001; 
Atkinson et al. 2010) did not identify any 
evidence of effects of coarse particles on 
hospital admissions for either cardio vascular 
or respiratory causes. A study conducted in 
six French cities (Host et al. 2008) found no 
association between coarse PM and cardio­
vascular or respiratory admissions, and 
reported only one statistically significant 
association with ischemic heart disease in the 
elderly. We identified positive associations 
of coarse particles with both cardiovascular 
(0.46% increase; 95% CI: 0.10, 0.82 with 
a 6.3­µg/m3 increase in lag 0–1 PM2.5–10) 
and respiratory admissions (1.24% increase; 
95% CI: –0.32, 2.82) with a 6.3­µg/m3 
increase in lag 0–5 PM2.5–10). Corresponding 
associations with a 10­µg/m3 increase in 
PM2.5–10 were higher than previously 
reported (0.73%; 95% CI: 0.16, 1.30%, and 
1.95%; 95% CI: –0.51, 4.48%, respectively). 
However, because PM2.5–10 is obtained as 
the difference between PM10 and PM2.5, it 
is affected by measurement error from two 
sources, and the direction and magnitude 
of the resulting bias in the associations with 
hospitalizations cannot be predicted.
Our study is, to our knowledge, the first 
study involving cities from multiple countries 
in Southern Europe and investigating the 
health effects of fine and coarse particles on 
cause­specific hospitalizations. Our estimates of 
associations between PM2.5 and cardio vascular 
admissions are slightly smaller than those 
reported by U.S. studies, whereas associations 
between PM2.5 and respiratory admissions, 
and associations between both outcomes and 
PM2.5–10, are more similar. Several differences 
must be acknowledged between our study and 
the North American ones. First, the chemi­
cal mixture of PM2.5 in Europe is likely to be 
different from that in the United States. For 
example, diesel powered cars make up 50% 
of the fleet in Europe and only about 2% in 
the United States. Consistent with this, ele­
mental carbon concentrations estimated for 
187 counties in the United States were about 
0.6 µg/m3 (Bell 2012) compared with about 
1.5 µg/m3 for Madrid and Barcelona (unpub­
lished data). Second, PM concentrations for 
most U.S. studies were measured every 3rd 
or 6th day, whereas daily PM measurements 
were available for the eight cities in the pres­
ent study. In addition, our study, along with 
the entire MED­PARTICLES project, com­
prises Southern European cities characterized 
by highly urbanized areas with intense traffic 
congestion, elevated sea traffic due to tourist 
and shipping activities over the Mediterranean 
area, mild meteorological conditions favor­
ing outdoor activities during most of the year, 
enhanced formation of secondary pollutants 
owing to intense solar radiation, high fre­
quency of wildfires, and Saharan dust advec­
tion episodes, especially in summer and spring.
Associations between fine particles and 
cardiovascular hospitalizations in our study 
were not affected by coarse PM co­exposure, 
but the associations of both fine and coarse 
PM with respiratory admissions decreased to 
nonsignificance when evaluated together in 
two­pollutant models. Because of moderate to 
high correlations between the two exposures, it 
is difficult to disentangle their potential effects. 
This problem was even more apparent in two­
pollutant models involving PM2.5 and NO2. 
The respiratory effects were highly hetero­
geneous, and there are no simple explanations 
for that. These heterogeneous effects were 
already seen in a large Italian study (Faustini 
et al. 2013). City­specific prevalence of patients 
with chronic respiratory conditions may be dif­
ferent, as may their individual level of response 
to air pollutants on different seasons.
An additional contribution of the pres­
ent study is the strategy for time­trend adjust­
ment. We applied three different approaches 
to adjust for the confounding effect of long­
term and seasonal time trends: a case­crossover 
approach that used three­way interaction 
terms among year, month, and day of the 
week (84 df per year) to adjust for time trends; 
a penalized spline and a smoothing param­
eter with 8 df per year; and a penalized spline 
with df per year selected to minimize PACF 
residuals (3–5 df per year for cardiovascular 
admissions, and 3–9 df per year for respira­
tory admissions). Despite the variation in the 
degrees of control, the three methods provided 
consistent results, suggesting little residual 
confounding due to long­term and seasonal 
time trends.
We estimated much stronger associations 
of fine and coarse particles with hospitaliza­
tions for both cardiovascular and respiratory 
conditions during the warm period compared 
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with the cold period. This is consistent with 
the worldwide literature (Faustini et al. 2013; 
Stieb et al. 2009; Strickland et al. 2010). 
Two complementary hypotheses have been 
suggested: First, exposures to air pollutants 
may increase during warm months because 
of increased outdoor activities and open win­
dows (Stafoggia et al. 2008); second, the air 
pollution mixture may include a greater pro­
portion of toxic components during warmer 
months (Peng et al. 2005). Both explanations 
are plausible during the warm season in the 
Mediterranean area because of seasonal differ­
ences in PM composition (Perrino et al. 2009; 
Querol et al. 2009; van Drooge et al. 2012) 
and an increased frequency of wildfires and 
Saharan dust episodes, whose particles have 
been related to health effects (Hänninen et al. 
2009; Karanasiou et al. 2012). These aspects 
have been already documented in the Southern 
Mediterranean countries (Querol et al. 2009), 
and further results will be available from the 
MED­PARTICLES project.
To our knowledge, this is the first study 
to investigate the concentration–response 
functions of fine and coarse particles with 
cardiovascular and respiratory morbidity. 
Epidemiological studies of the short­term 
effects of PM10 on cause­specific mortality 
(Daniels et al. 2004; Faustini et al. 2011; 
Katsouyanni et al. 2009) have reported no 
apparent departures from linearity. An 
extension of the Harvard Six Cities Study 
also reported no evidence of a departure 
from linearity for the relationship between 
long­term exposure to PM2.5 and survival 
(Schwartz et al. 2008). In the present study 
we found a suggestion of linear effects of all 
PM metrics on respiratory hospitalizations, 
and of PM2.5–10 on cardiovascular admissions. 
However, the slopes of estimated exposure–
response curves for cardiovascular admissions 
in association with PM10 and PM2.5 were 
steeper for low to moderate concentrations 
(approximately 30 µg/m3 for PM2.5 and 
60 µg/m3 for PM10) than higher concentra­
tions, consistent with the dose–response curve 
previously estimated for the long­term effects 
of PM2.5 on mortality from ischemic heart 
disease (Pope et al. 2009). These results need 
further investigation in other locations and 
with other analytical approaches, but they 
support effects of all PM metrics on cardio­
vascular and respiratory conditions at low con­
centrations, including concentrations below 
the current EU air quality standards.
We believe that our results have clear 
implications for the EU policy on air qual­
ity. Specifically, they suggest that the current 
24­hr daily limit value for PM10 in Europe is 
not sufficient to protect the population from 
short­term effects, and that a daily limit value 
for PM2.5 is clearly warranted. Both PM2.5 
and PM10 daily limits are needed to control 
air pollution generated from different sources: 
vehicle exhausts and combustion sources for 
fine particles, natural sources together with 
resuspension of road dust (containing a 
mixture of soil, tire wear, and brake wear), 
non­exhaust emissions, and commercial and 
industrial residues for coarse particles. Because 
coarse particles of natural origin cannot be 
controlled, policy measures aimed at control­
ling anthropogenic sources of coarse particles 
would be advisable. Alternatively, a specific 
short­term limit value for coarse particles 
(PM2.5–PM10) may be considered, but only in 
addition to an effective PM2.5 daily limit.
Conclusions
In summary, we estimated significant short­
term effects of fine and coarse particles on car­
diovascular and respiratory hospitalizations in 
eight Southern European cities. Associations 
were similar across PM metrics, stronger but 
more heterogeneous for respiratory admis­
sions, much more pronounced during the 
warm period, and robust to time­trend speci­
fication. In addition, we did not find strong 
evidence of departure from linearity in the 
range of pollutant concentrations measured 
for the associations under investigation. These 
findings will help inform planned revisions of 
EU air quality standards and support legisla­
tion on daily PM2.5 concentrations to better 
target policies on air pollution in Europe.
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